Sandoz Patent For IBS-Treating Antibiotic Fails On Appeal
Sandoz AG has lost its bid to patent a new method for preparing rifaximin, after European patent officers ruled that the tweaked treatment for traveler's diarrhea and other gastrointestinal conditions was...To view the full article, register now.
Already a subscriber? Click here to view full article